PHILADELPHIA & JACKSONVILLE, Fla.–(BUSINESS WIRE)– #diabeticeyewear–Ophthalmic Goods Manufacturing startups Bon Vivant Safety Eyewear Company, Inc. and Tioga Optical Lab QOZB, LLC, founded by Anthony B. Miles, US Navy Trident Nuclear Submarine Force…
Category: Business
LENSRXLAB Introduces Groundbreaking Vision Benefits Platform Catered to Diabetic Individuals
PHILADELPHIA–(BUSINESS WIRE)– #benefits–LENSRXLAB, a leading provider of diabetic, safety, and dress eyewear, announces the launch of its Supplemental Vision Benefits Platform for Diabetics, aiming to revolutionize vision care. Founded by a Military…
Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Frontiers in Ophthalmology published statistically significant res…
BrightFocus Foundation Announces $10M in New Funding Across Brain and Vision Research, Celebrates Historic Diversity of Grant Award Recipients
CLARKSBURG, Md.–(BUSINESS WIRE)–Global nonprofit BrightFocus Foundation announces $10 million in new Alzheimer’s disease, macular degeneration, and glaucoma research grant funding—age-related diseases with no cure that affect more than 335 million pe…
Collective Health Expands National Footprint into Texas with Grand Opening of Office in Plano
PLANO, Texas–(BUSINESS WIRE)–Collective Health, the leading employee health benefits platform with integrated member advocacy, clinical navigation, and an extensive partner ecosystem, today unveiled its newest office location in the Dallas suburb of …
NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare and wound care products, announces a new and enhanced marketing program that includes text message c…
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that on April 18, 2024 it received a notice from the NYSE American LLC stating that the Company is below compliance with the NYSE American continued list…
Warby Parker to Announce First Quarter 2024 Financial Results on May 9, 2024
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the first quarter ended March 31, 2024 will be released before mar…
Introducing RevEngage: Patient Communication Simplified
SAN DIEGO–(BUSINESS WIRE)–RevolutionEHR, the leading provider of optometry practice management software, has released its robust new patient engagement solution, RevEngage.
Alivi Health Unveils Innovative Vision Program, Setting a New Standard in Healthcare Offerings
MIAMI–(BUSINESS WIRE)–Alivi Health, a leading provider of transportation, card-based, and specialty benefits, unveils a new Vision Program, a groundbreaking service designed to elevate medical centers’ offerings and enhance member satisfaction. The c…
GenSight Biologics Announces the Filing of its 2023 Universal Registration Document
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programs
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its ONE by ONE and Biotrue® Eye Care Recycling programs have colle…
Pantheon Vision Announces Two Successful Pre-Submission Meetings With the FDA
BALTIMORE–(BUSINESS WIRE)–Pantheon Vision, a pre-clinical stage medical device company developing bioengineered corneal implants to eliminate corneal blindness, announced today the completion of two successful and productive Pre-Submission meetings w…
NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports preliminary net revenue for its eyecare and wound care business for the first quarter of 2024 of $2.6 million, a 13% increase from the first quarter of 202…
Glaukos Announces the Release of its 2023 Sustainability Report
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that i…
Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release first…
iHealthScreen Inc. is Awarded a US Patent on Glaucoma Detection, Which Is Based on AI and Color Fundus Imaging
NEW YORK–(BUSINESS WIRE)– #AI–iPredictTM glaucoma detection model provides a fully automated detection report for glaucoma which can be implemented in the primary care settings for screening and detection of early-stage glaucoma. The full US patent …
Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Interim Data from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on April 10, 2024
CAMBRIDGE, Mass.–(BUSINESS WIRE)—- $AMLX–Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the Company will host a virtual webcast with management and Fumihiko Urano, MD, PhD, Principal Investigator of the HELI…
拨康视云(Cloudbreak Pharma) 最新调查结果凸显眼疾负担,彰顯非手术治疗选项对于被低估和未充分治疗的翼状胬肉眼疾的重要性
加州尔湾–(BUSINESS WIRE)–(美国商业资讯)– 拨康视云是一家临床阶段的生物技术公司,致力于开发治疗常见但治療方案甚少的眼科疾病的药物。該公司在波士顿举行的年度ASCRS会议上分享了一项由公司支持的调查数据,该调查彰顯了翼状胬肉的患者负担。翼状胬肉是一种眼部疾病,通常被称为“冲浪者眼”,可能是暴露于高水平紫外线辐射環境而引起的。1 这项横断面调查显示,50%的受访者报告称翼状胬肉对他们的生活产生了相当大的影响,經常干扰他们进行日常活动的能力。2超过一半的受访患者还表示环境因素,如…
New Survey Results from Cloudbreak Pharma Highlight Disease Burden, Need for Non-surgical Treatment Options for Underdiagnosed and Undertreated Ocular Disease
IRVINE, Calif.–(BUSINESS WIRE)–Cloudbreak Pharma, a clinical stage biotechnology company developing ophthalmic drugs for common eye diseases with few treatment options, shared new data from a company-supported survey highlighting the patient burden o…